Evidence map›Paper›PMID 25030625›Full record

ArticleNeoplasia (New York, N.Y.)2014

Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.

Asunción Fernández-Barral, Jose Luis Orgaz, Pablo Baquero, Zaheer Ali, Alberto Moreno, María Tiana, Valentí Gómez, Erica Riveiro-Falkenbach, Carmen Cañadas, Sandra Zazo and 8 more

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Non-alcoholic fatty liver disease and liver secretome.Archives of pharmacal research · 2022
    Review
  4. Article
  5. Review
  6. Photoreceptor degeneration in microphthalmia (Disease models & mechanisms · 2019
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 4 countries.

Asunción Fernández-BarralDepartment of Biochemistry, Universidad Autónoma de Madrid, Spain; Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM Madrid, Spain.
Jose Luis OrgazDepartment of Biochemistry, Universidad Autónoma de Madrid, Spain; Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM Madrid, Spain; Randall Division of Cell and Molecular Biophysics, New Hunt's House, Guy's Campus, King's College London, London SE1UL, United Kingdom.
Pablo BaqueroDepartment of Biochemistry, Universidad Autónoma de Madrid, Spain; Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM Madrid, Spain; Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Zaheer AliDivision of Cardiovascular Medicine, Department of Medical and Health sciences, Linköping University, Linköping, Sweden.
Alberto MorenoInstituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM Madrid, Spain; Centre for Gene Regulation & Expression, College of Life Sciences, Universtity of Dundee, Dundee DD1 5EH, United Kingdom.
María TianaDepartment of Biochemistry, Universidad Autónoma de Madrid, Spain; Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM Madrid, Spain.
Valentí GómezDepartment of Biochemistry, Universidad Autónoma de Madrid, Spain; Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM Madrid, Spain; Tumor Suppressor Signaling Networks Laboratory, UCL Cancer Institute, University College London, WC1E 6BT, London, United Kingdom.
Erica Riveiro-FalkenbachDepartment of Pathology, Hospital Universitario 12 de Octubre, Universidad Complutense, Madrid, Spain; Instituto de Investigación I+12, Madrid, Spain.
Carmen CañadasDepartment of Pathology, Capio-Fundación Jimenez Díaz, Madrid, Spain.
Sandra ZazoDepartment of Pathology, Capio-Fundación Jimenez Díaz, Madrid, Spain.
Corine BertolottoINSERM U895 Team 1 and Department of Dermatology, CHU Nice, France.
Irwin DavidsonInstitute de Génétique et de Biologie Moléculaire et Cellulaire, CNRS, INSERM, Université de Strasbourg, Illkirch, France.
Jose Luis Rodríguez-PeraltoDepartment of Pathology, Hospital Universitario 12 de Octubre, Universidad Complutense, Madrid, Spain; Instituto de Investigación I+12, Madrid, Spain.
Ignacio PalmeroInstituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM Madrid, Spain.
Federico RojoDepartment of Pathology, Capio-Fundación Jimenez Díaz, Madrid, Spain.
Lasse Dahl JensenDivision of Cardiovascular Medicine, Department of Medical and Health sciences, Linköping University, Linköping, Sweden.
Luis del PesoDepartment of Biochemistry, Universidad Autónoma de Madrid, Spain; Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM Madrid, Spain.
Benilde JiménezDepartment of Biochemistry, Universidad Autónoma de Madrid, Spain; Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM Madrid, Spain; Instituto de Investigación I+12, Madrid, Spain. Electronic address: bjimenez@iib.uam.es.
Universidad Autónoma de Madrid · ESHospital Universitario Fundación Jiménez Díaz · ESInstituto de Investigaciones Biomédicas Sols-Morreale · ESLinköping University · SEHospital Universitario 12 De Octubre · ESInserm · FRUnidad de Investigación en cuidados y servicios de salud (Investén-isciii) · ESUniversité de Strasbourg · FR

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
NIH HHS P51 OD011132
6 · The paper itself

Abstract

Pigment epithelium-derived factor (PEDF), a member of the serine protease inhibitor superfamily, has potent anti-metastatic effects in cutaneous melanoma through its direct actions on endothelial and melanoma cells. Here we show that PEDF expression positively correlates with microphthalmia-associated transcription factor (MITF) in melanoma cell lines and human samples. High PEDF and MITF expression is characteristic of low aggressive melanomas classified according to molecular and pathological criteria, whereas both factors are decreased in senescent melanocytes and naevi. Importantly, MITF silencing down-regulates PEDF expression in melanoma cell lines and primary melanocytes, suggesting that the correlation in the expression reflects a causal relationship. In agreement, analysis of Chromatin immunoprecipitation coupled to high throughput sequencing (ChIP-seq) data sets revealed three MITF binding regions within the first intron of SERPINF1, and reporter assays demonstrated that the binding of MITF to these regions is sufficient to drive transcription. Finally, we demonstrate that exogenous PEDF expression efficiently halts in vitro migration and invasion, as well as in vivo dissemination of melanoma cells induced by MITF silencing. In summary, these results identify PEDF as a novel transcriptional target of MITF and support a relevant functional role for the MITF-PEDF axis in the biology of melanoma.

Indexed as

AnimalsCell Line, TumorCell MovementCellular SenescenceDisease ProgressionEpistasis, GeneticEye ProteinsGene ExpressionGene Expression Regulation, NeoplasticHumansMelanocytesMelanomaMicrophthalmia-Associated Transcription FactorNeoplasm MetastasisNerve Growth FactorsPigment Epithelium-Derived FactorEye ProteinsMicrophthalmia-Associated Transcription FactorNerve Growth FactorsPigment Epithelium-Derived FactorSerpinsAbbreviationsBRAFCMcutaneous metastasis of melanomaheterogeneous nuclear RNAhnRNAmicrophthalmia-associated transcription factorMITFneuroblastoma RAS viral (v-ras) oncogene homologNRASOISoncogene induced senescencePEDFpigment epithelium-derived factorradial growth phase of melanomaRGPvertical growth phase of melanomaVGPvisceral metastasis of melanomaVMv-raf murine sarcoma viral oncogene homolog B

Identifiers

PMID25030625
PMCPMC4198745
OpenAlexW2014329148

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.